missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human HTR4 (aa 319-387) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (91%), Rat (91%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene is a member of the family of serotonin receptors, which are G protein coupled receptors that stimulate cAMP production in response to serotonin (5-hydroxytryptamine). The gene product is a glycosylated transmembrane protein that functions in both the peripheral and central nervous system to modulate the release of various neurotransmitters. Multiple transcript variants encoding proteins with distinct C-terminal sequences have been described, but the full-length nature of some transcript variants has not been determined.
Specifications
Specifications
| Accession Number | Q13639 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 3360 |
| Name | Human HTR4 (aa 319-387) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 5 hydroxytryptamine (serotonin) receptor 4; 5 hydroxytryptamine (serotonin) receptor 4; 5 HT4; 5-HT4; 5-HT-4; 5 HT4 receptor; 5-HT4 receptor; 5-HT4 receptor (two splicing variants L and S); 5-HT4R; 5 HTR4; 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled; 5-hydroxytryptamine receptor 4; cardiac 5-HT4 receptor; Htr4; Serotonin receptor 4 |
| Common Name | HTR4 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction